The White House reached out to social media influencers in an effort to encourage younger Americans to get a COVID-19 vaccination and to fight online misinformation. Some state and local governments also are using influencers, including the state of Colorado, which awarded $16.4 million to Denver-based Idea Marketing.

The medical device user fee for a premarket approval application has been raised 2.5% for fiscal 2022. The base fee for a PMA received during fiscal 2022 is $329,000, and the standard fee for a PMA that includes biologics license application, premarket report and a BLA efficacy supplement is $374,858.

An NIH bioethics panel suggested that genetics research participants be informed about findings that show participants are at risk for a potentially treatable or preventable condition, unless participants deliberately opt out. However, some researchers say more studies are needed before changing the current opt-in system to opt-out, particularly as it pertains to Black participants.

Global Blood Therapeutics "My Time" television ads promote its sickle cell disease treatment Oxbryta by telling patients with the disease, "it's your time to experience less sickling." GBT's online campaign, launched in 2020, has a similar message and encourages patients to "Imagine less sickling."

Ads focused on Alzheimer's disease caregivers and child abuse are part of advertising campaigns that inspire, according to Adan Romero, senior vice president and executive creative director for Rauxa. Also included is a Mucinex campaign that encouraged consumers to wear a mask during the COVID-19 pandemic.

-- Mediahub CEO Sean Corcoran commenting in a Campaign US story about problems attracting new talent.

Siemens Healthineers generated $5.93 billion in revenue during its fiscal third quarter, which ended June 30. This represents a 38.9% increase in revenue over the same quarter last year.

Todos Medical has completed its $10 million acquisition of Provista Diagnostics and its Videssa breast cancer blood test after making the final payment of $1.25 million.

DiaSorin generated $295.4 million in revenue during its second quarter, up 20% from the previous year.

SeaSpine generated $47.5 million in sales during its second quarter, which ended June 30. "We are exceptionally well-positioned to further expand our presence across the U.S. in both the hospital and ambulatory surgery center settings," said SeaSpine president & CEO Keith Valentine.